Status | Study |
Active, not recruiting |
Study Name: Study of Autologous Mesenchymal Stem Cells to Treat Idiopathic Pulmonary Fibrosis Condition: Idiopathic Pulmonary Fibrosis Date: 2013-08-01 Interventions: Biological: Endobronchial infusion of adult mesenchymal stem cells |
Recruiting |
Study Name: Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry Condition: Idiopathic Pulmonary Fibrosis Date: 2013-07-31 |
Active, not recruiting |
Study Name: Evaluate the Safety and Efficacy of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis Condition: Idiopathic Pulmonary Fibrosis Date: 2013-06-24 Interventions: Drug: FG-3019 |
Completed |
Study Name: Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With Cotrimoxazole Condition: Idiopathic Pulmonary Fibrosis Date: 2013-01-25 Interventions: Drug: Cotrimoxazole 24 weeks o |
Completed |
Study Name: The Role of Gastric Content Microaspirations in the Pathogenesis of Idiopathic Pulmonary Fibrosis Condition: IDIOPATHIC PULMONARY FIBROSIS Date: 2012-10-23 |
Withdrawn |
Study Name: A MultiCenter Study of Combined PEX, Rituximab, and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations Condition: Idiopathic Pulmonary Fibrosis Date: 2012-01-27 Interventions: Drug: Standard Steroid Treatment |
Recruiting |
Study Name: Exercise Training at Ambulatory Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis Patients Condition: Idiopathic Pulmonary Fibrosis Date: 2011-12-20 Interventions: Behavioral: Pulmonary Rehabilitation Exercise Training in |
Completed |
Study Name: A Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis Condition: Idiopathic Pulmonary Fibrosis Date: 2011-05-04 Interventions: Other: Placental MSC MSC will be derived from mothers donating their term placenta for clinical trial re |
Withdrawn |
Study Name: Safety and Tolerability Study of Macitentan in Patients With Idiopathic Pulmonary Fibrosis Condition: Idiopathic Pulmonary Fibrosis Date: 2011-05-02 Interventions: Drug: Macitentan 10 mg, tablet, once daily |
Terminated |
Study Name: Peripheral Blood Biomarkers in Idiopathic Interstitial Pneumonias Condition: Idiopathic Interstitial Pneumonias Date: 2010-06-25 |